Charles River Laboratories International, Inc. (CRL)
NYSE: CRL · Real-Time Price · USD
155.55
-2.51 (-1.59%)
At close: Mar 28, 2025, 4:00 PM
154.36
-1.19 (-0.77%)
Pre-market: Mar 31, 2025, 7:53 AM EDT

CRL Market Cap

CRL has a market cap or net worth of $7.96 billion as of March 31, 2025. Its market cap has decreased by -40.68% in one year.

Market Cap
7.96B
Enterprise Value
10.54B
1-Year Change
-40.68%
Ranking
Category
Stock Price
$155.55

Market Cap Chart

Since June 23, 2000, CRL's market cap has increased from $226.30M to $7.96B, an increase of 3,415.28%. That is a compound annual growth rate of 15.45%.

History

DateMarket Cap% Change
Mar 28, 20257.96B-15.73%
Dec 31, 20249.44B-22.16%
Dec 29, 202312.13B9.38%
Dec 30, 202211.09B-41.69%
Dec 31, 202119.01B52.98%
Dec 31, 202012.43B66.59%
Dec 31, 20197.46B37.05%
Dec 31, 20185.44B5.01%
Dec 29, 20175.18B43.75%
Dec 30, 20163.61B-3.79%
Dec 31, 20153.75B25.52%
Dec 31, 20142.99B17.00%
Dec 31, 20132.55B40.28%
Dec 31, 20121.82B34.64%
Dec 30, 20111.35B-34.13%
Dec 31, 20102.05B-7.60%
Dec 31, 20092.22B25.20%
Dec 31, 20081.77B-60.32%
Dec 31, 20074.47B54.46%
Dec 29, 20062.89B-5.57%
Dec 30, 20053.06B2.77%
Dec 31, 20042.98B89.75%
Dec 31, 20031.57B-9.52%
Dec 31, 20021.74B17.55%
Dec 31, 20011.48B50.25%
View and export this data all the way back to 2000. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 738.61B
UnitedHealth Group 472.03B
Johnson & Johnson 394.52B
AbbVie 363.15B
Novo Nordisk 305.46B
AstraZeneca 229.16B
Abbott Laboratories 226.88B
Merck & Co. 225.40B
Market Cap Rankings